المؤلفون: Ceregido Ma, De Barros E, Luyts D, Mesaros N, Sancovski M, Feng Y

المصدر: Human Vaccines & Immunotherapeutics

مصطلحات موضوعية: Adult, medicine.medical_specialty, Adolescent, Whooping Cough, 030231 tropical medicine, Immunology, adverse event, Diphtheria-Tetanus-acellular Pertussis Vaccines, 03 medical and health sciences, Young Adult, 0302 clinical medicine, Pertussis, Pregnancy, Risk Factors, medicine, Immunology and Allergy, Humans, 030212 general & internal medicine, Adverse effect, Retrospective Studies, Pharmacology, Antigens, Bacterial, Tetanus, Obstetrics, business.industry, Immunization Programs, Diphtheria, Infant, Newborn, Retrospective cohort study, medicine.disease, Gestational diabetes, Vaccination, maternal vaccination, Small for gestational age, Female, Pregnant Women, neonate, business, Brazil, Research Paper

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::df9b95e0c8db82c6bfec1e0eca84d2e0
http://europepmc.org/articles/PMC6930109

المؤلفون: Martinon-Torres, F, Halperin, SA, Nolan, T, Tapiero, B, Perrett, KP, Salamanca de la Cueva, I, Garcia-Sicilia, J, Stranak, Z, Vanderkooi, OG, Kosina, P, Rumlarova, S, Virta, M, Merino Arribas, JM, Miranda-Valdivieso, M, Arias Novas, B, Bozensky, J, Cilleruelo Ortega, MJ, Ramos Amador, JT, Baca, M, Escribano Palomino, E, Zuccotti, GV, Janota, J, Marchisio, PG, Kostanyan, L, Meyer, N, Ceregido, MA, Cheuvart, B, Kuriyakose, SO, Mesaros, N

مصطلحات الفهرس: Journal Article

URL: http://hdl.handle.net/11343/309455

المؤلفون: Roman F; GSK, Wavre, Belgium., Burny W; GSK, Rixensart, Belgium., Ceregido MA; GSK, Madrid, Spain., Laupèze B; GSK, Wavre, Belgium., Temmerman ST; GSK, Rixensart, Belgium., Warter L; GSK, Rixensart, Belgium., Coccia M; GSK, Rixensart, Belgium.

المصدر: Expert review of vaccines [Expert Rev Vaccines] 2024 Jan-Dec; Vol. 23 (1), pp. 715-729. Date of Electronic Publication: 2024 Aug 05.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: Taylor & Francis Country of Publication: England NLM ID: 101155475 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1744-8395 (Electronic) Linking ISSN: 14760584 NLM ISO Abbreviation: Expert Rev Vaccines Subsets: MEDLINE

مواضيع طبية MeSH: Saponins*/immunology , Saponins*/pharmacology , Adjuvants, Immunologic*/administration & dosage , Adjuvants, Immunologic*/pharmacology , Adjuvants, Vaccine*, Humans ; Lipid A/analogs & derivatives ; Lipid A/immunology ; Lipid A/pharmacology ; Animals ; Immunity, Innate/drug effects ; Respiratory Syncytial Virus Vaccines/immunology ; Liposomes ; Malaria/prevention & control ; Malaria/immunology ; Malaria Vaccines/immunology ; Malaria Vaccines/administration & dosage ; Drug Combinations

المؤلفون: Dayan GH; Sanofi, Swiftwater, PA, USA. Electronic address: gustavo.dayan@sanofi.com., Rouphael N; Emory University Hope Clinic, Atlanta, GA, USA., Walsh SR; Harvard Medical School, Boston, MA, USA., Chen A; Sanofi, Swiftwater, PA, USA., Grunenberg N; Fred Hutchinson Cancer Center, Seattle, WA, USA., Allen M; National Institute of Allergy and Infectious Diseases / National Institutes of Health, Bethesda, MD, USA., Antony J; Sanofi, Frankfurt, Germany., Asante KP; Research and Development Division, Ghana Health Service, Kintampo North Municipality, Ghana., Bhate AS; Jeevan Rekha Hospital, Belgavi, India., Beresnev T; National Institute of Allergy and Infectious Diseases / National Institutes of Health, Bethesda, MD, USA., Bonaparte MI; Sanofi, Swiftwater, PA, USA., Celle M; Sanofi, Marcy l'Etoile, France., Ceregido MA; GlaxoSmithKline, Wavre, Belgium., Corey L; Fred Hutchinson Cancer Center, Seattle, WA, USA., Dobrianskyi D; Medical Centre, Medical Clinic Blagomed, Kyiv, Ukraine., Fu B; National Institute of Allergy and Infectious Diseases / National Institutes of Health, Bethesda, MD, USA., Grillet MH; Sanofi, Lyon, France., Keshtkar-Jahromi M; National Institutes of Health, Rockville, MD, USA; John Hopkins University School of Medicine, Baltimore, MD, USA., Juraska M; Fred Hutchinson Cancer Center, Seattle, WA, USA., Kee JJ; Fred Hutchinson Cancer Center, Seattle, WA, USA., Kibuuka H; Makerere University Walter Reed Project, Kampala, Uganda., Koutsoukos M; GlaxoSmithKline, Wavre, Belgium., Masotti R; Sanofi, Swiftwater, PA, USA., Michael NL; Walter Reed Army Institute of Research, Silver Spring, MD, USA., Neuzil KM; University of Maryland School of Medicine, Baltimore, MD, USA., Reynales H; Centro de Attencion e Investigation Medica S.A.S. - Caimed Chía, Chía, Colombia., Robb ML; The Henry M Jackson Foundation for the Advancement of Military Medicine, Bethesda, MA, USA., Villagómez Martínez SM; Hospital de Temixco en acuerdo con el Instituto Nacional de Pediatria, Temixco, México., Sawe F; Kenya Medical Research Institute - US Army Medical Research, Kericho, Kenya., Schuerman L; GlaxoSmithKline, Wavre, Belgium., Tong T; National Institute of Allergy and Infectious Diseases / National Institutes of Health, Bethesda, MD, USA., Treanor J; Tunnell Government Services in support of Biomedical Advanced Research and Development Authority, Administration for Strategic Preparedness and Response, Department of Health and Human Services, Washington, DC, USA., Wartel TA; International Vaccine Institute, Seoul, South Korea., Diazgranados CA; Sanofi, Swiftwater, PA, USA., Chicz RM; Sanofi, Cambridge, MA, USA., Gurunathan S; Sanofi, Swiftwater, PA, USA., Savarino S; Sanofi, Swiftwater, PA, USA., Sridhar S; Sanofi, Reading, UK.

مؤلفون مشاركون: VAT00008 Study Team

المصدر: The Lancet. Respiratory medicine [Lancet Respir Med] 2023 Nov; Vol. 11 (11), pp. 975-990. Date of Electronic Publication: 2023 Sep 13.

نوع المنشور: Randomized Controlled Trial; Clinical Trial, Phase III; Journal Article; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural

بيانات الدورية: Publisher: Elsevier Country of Publication: England NLM ID: 101605555 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2213-2619 (Electronic) Linking ISSN: 22132600 NLM ISO Abbreviation: Lancet Respir Med Subsets: MEDLINE

مواضيع طبية MeSH: COVID-19*/prevention & control , Vaccines*, Adult ; Female ; Humans ; Male ; COVID-19 Vaccines ; Double-Blind Method ; SARS-CoV-2/genetics ; Vaccines, Combined ; Adolescent ; Young Adult ; Middle Aged

SCR Organism: SARS-CoV-2 variants

المؤلفون: Dayan GH; Sanofi, Swiftwater, PA, USA., Rouphael N; Hope Clinic, Emory University, Atlanta, GA, USA., Walsh SR; Harvard Medical School, Boston, MA, USA., Chen A; Sanofi, Swiftwater, PA, USA., Grunenberg N; Fred Hutchinson Cancer Center, Seattle, WA, USA., Allen M; National Institute of Allergy and Infectious Diseases / National Institutes of Health, Bethedsa, MD, USA., Antony J; Sanofi, Frankfurt, Germany., Bhate AS; Jeevan Rekha Hospital, Belgavi, India., Beresnev T; National Institute of Allergy and Infectious Diseases / National Institutes of Health, Bethedsa, MD, USA., Bonaparte MI; Sanofi, Swiftwater, PA, USA., Celle M; Sanofi, Marcy l'Etoile, France., Ceregido MA; GSK, Wavre, Belgium., Corey L; Fred Hutchinson Cancer Center, Seattle, WA, USA., Fu B; Sanofi, Swiftwater, PA, USA., Grillet MH; Sanofi, Lyon, France., Keshtkar-Jahromi M; National Institute of Health, Rockville, MD, USA.; John Hopkins University School of Medicine, Baltimore, MD, USA., Juraska M; Fred Hutchinson Cancer Center, Seattle, WA, USA., Kee JJ; Fred Hutchinson Cancer Center, Seattle, WA, USA., Kaali S; Research and Development Division, Ghana Health Service, Kintampo North Municipality, Ghana., Koutsoukos M; GSK, Wavre, Belgium., Masotti R; Sanofi, Swiftwater, PA, USA., Michael NL; Walter Reed Army Institute of Research, MD, USA., Neuzil KM; University of Maryland School of Medicine, Baltimore, MD, USA., Reynales H; Centro de Attencion e Investigation Medica S.A.S. - Caimed Chía, Chía, Colombia., Robb ML; The Henry M Jackson Foundation for the Advancement of Military Medicine, Bethesda, MA, USA., Uchiyama A; Medical Corporation Asbo Tokyo Asbo Clinic, Tokyo, Japan., Sawe F; Kenya Medical Research Institute - US Army Medical Research, Kisumu, Kenya., Schuerman L; GSK, Wavre, Belgium., Shrestha R; Center for Clinical Trial Studies, Dhulikhel Hospital, Kathmandu University Hospital, Dhulikhel, Nepal., Tong T; National Institute of Allergy and Infectious Diseases / National Institutes of Health, Bethedsa, MD, USA., Treanor J; Department of Health and Human Services (HHS), Tunnell Government Services in Support of Biomedical Advanced Research and Development Authority (BARDA), Administration for Strategic Preparedness and Response (ASPR), Washington, DC, USA., Diazgranados CA; Sanofi, Swiftwater, PA, USA., Chicz RM; Sanofi, Waltham, MA, USA., Gurunathan S; Sanofi, Swiftwater, PA, USA., Savarino S; Sanofi, Swiftwater, PA, USA., Sridhar S; Sanofi, Reading, UK.

مؤلفون مشاركون: VAT00008 study team

المصدر: EClinicalMedicine [EClinicalMedicine] 2023 Sep 12; Vol. 64, pp. 102168. Date of Electronic Publication: 2023 Sep 12 (Print Publication: 2023).

نوع المنشور: Journal Article

بيانات الدورية: Publisher: The Lancet Country of Publication: England NLM ID: 101733727 Publication Model: eCollection Cited Medium: Internet ISSN: 2589-5370 (Electronic) Linking ISSN: 25895370 NLM ISO Abbreviation: EClinicalMedicine Subsets: PubMed not MEDLINE

المؤلفون: de Bruyn G; Sanofi, Swiftwater, PA, USA., Wang J; Sanofi, Chengdu, China., Purvis A; Sanofi, Waltham, MA, USA., Ruiz MS; Sanofi, Paris, France., Adhikarla H; Sanofi, Swiftwater, PA, USA., Alvi S; Chicago Clinical Research Institute, IL, USA., Bonaparte MI; Sanofi, Swiftwater, PA, USA., Brune D; Optimal Research, Peoria, IL, USA., Bueso A; Demedica, San Pedro Sula, Honduras., Canter RM; Sanofi, Swiftwater, PA, USA., Ceregido MA; GSK, Wavre, Belgium., Deshmukh S; Griffith University, Australia., Diemert D; School of Medicine and Health Sciences, George Washington University, Washington, DC, USA., Finn A; Bristol Vaccine Centre, Schools of Population Health Sciences and of Cellular and Molecular Medicine, University of Bristol, Bristol, UK., Forrat R; Sanofi, Marcy l'Etoile, France., Fu B; Sanofi, Swiftwater, PA, USA., Gallais J; Sanofi, Marcy l'Etoile, France., Griffin P; Mater Health, Brisbane, Queensland, Australia.; The University of Queensland, Brisbane, Queensland, Australia., Grillet MH; Sanofi, Lyon, France., Haney O; Sanofi, Swiftwater, PA, USA., Henderson JA; Black Hills Center for American Indian Health, SD, USA., Koutsoukos M; GSK, Wavre, Belgium., Launay O; Université Paris Cité; Inserm, F-CRIN I REIVAC, Assistance Publique Hôpitaux de Paris, Hôpital Cochin, Paris, France., Torres FM; Pediatrics Department, Translational Pediatrics and Infectious Diseases Section, Santiago de Compostela, Spain.; Genetics, Vaccines- Infectious Diseases and Pediatrics Research Group GENVIP, Instituto de Investigación Sanitaria de Santiago (IDIS), Universidade de Santiago de Compostela (USC), Santiago de Compostela, Spain.; Centro de Investigación Biomédica en Red de Enfermedades Respiratorias (CIBERES), Instituto de Salud Carlos III, Madrid, Spain., Masotti R; Sanofi, Swiftwater, PA, USA., Michael NL; Walter Reed Army Institute of Research, Silver Spring, MD, USA., Park J; Sanofi, Sydney, Australia., Rivera-Medina DM; INVERIME S.A, Tegucigalpa, Honduras., Romanyak N; Sanofi, Swiftwater, PA, USA., Rook C; Cmax, Adelaide, Australia., Schuerman L; GSK, Wavre, Belgium., Sher LD; Peninsula Research Associates, Rolling Hills Estates, CA, USA., Tavares-Da-Silva F; GSK, Wavre, Belgium., Whittington A; London North West University Healthcare NHS Trust, London, UK., Chicz RM; Sanofi, Waltham, MA, USA., Gurunathan S; Sanofi, Swiftwater, PA, USA., Savarino S; Sanofi, Swiftwater, PA, USA., Sridhar S; Sanofi, Reading, UK.

مؤلفون مشاركون: VAT00002 booster cohorts study team

المصدر: EClinicalMedicine [EClinicalMedicine] 2023 Jul 22; Vol. 62, pp. 102109. Date of Electronic Publication: 2023 Jul 22 (Print Publication: 2023).

نوع المنشور: Journal Article

بيانات الدورية: Publisher: The Lancet Country of Publication: England NLM ID: 101733727 Publication Model: eCollection Cited Medium: Internet ISSN: 2589-5370 (Electronic) Linking ISSN: 25895370 NLM ISO Abbreviation: EClinicalMedicine Subsets: PubMed not MEDLINE

المؤلفون: Florea A; Department of Research and Evaluation, Southern California Permanente Medical Group, Kaiser Permanente Southern California, Kaiser Permanente, 100 S Los Robles Ave, 2nd Floor, Pasadena, CA, 91101, USA. Ana.Florea@kp.org., Sy LS; Department of Research and Evaluation, Southern California Permanente Medical Group, Kaiser Permanente Southern California, Kaiser Permanente, 100 S Los Robles Ave, 2nd Floor, Pasadena, CA, 91101, USA., Ackerson BK; Pediatrics and Pediatric Infectious Diseases, Southern California Permanente Medical Group, Harbor City, CA, USA., Qian L; Department of Research and Evaluation, Southern California Permanente Medical Group, Kaiser Permanente Southern California, Kaiser Permanente, 100 S Los Robles Ave, 2nd Floor, Pasadena, CA, 91101, USA., Luo Y; Department of Research and Evaluation, Southern California Permanente Medical Group, Kaiser Permanente Southern California, Kaiser Permanente, 100 S Los Robles Ave, 2nd Floor, Pasadena, CA, 91101, USA., Becerra-Culqui T; Department of Research and Evaluation, Southern California Permanente Medical Group, Kaiser Permanente Southern California, Kaiser Permanente, 100 S Los Robles Ave, 2nd Floor, Pasadena, CA, 91101, USA.; Department of Occupational Therapy, California State University, Dominguez Hills, Carson, CA, USA., Lee GS; Department of Research and Evaluation, Southern California Permanente Medical Group, Kaiser Permanente Southern California, Kaiser Permanente, 100 S Los Robles Ave, 2nd Floor, Pasadena, CA, 91101, USA., Tian Y; Department of Research and Evaluation, Southern California Permanente Medical Group, Kaiser Permanente Southern California, Kaiser Permanente, 100 S Los Robles Ave, 2nd Floor, Pasadena, CA, 91101, USA.; Pharmaceutical Product Development, Thermo Fisher Scientific, Wilmington, NC, USA., Zheng C; Department of Research and Evaluation, Southern California Permanente Medical Group, Kaiser Permanente Southern California, Kaiser Permanente, 100 S Los Robles Ave, 2nd Floor, Pasadena, CA, 91101, USA., Bathala R; Department of Research and Evaluation, Southern California Permanente Medical Group, Kaiser Permanente Southern California, Kaiser Permanente, 100 S Los Robles Ave, 2nd Floor, Pasadena, CA, 91101, USA., Tartof SY; Department of Research and Evaluation, Southern California Permanente Medical Group, Kaiser Permanente Southern California, Kaiser Permanente, 100 S Los Robles Ave, 2nd Floor, Pasadena, CA, 91101, USA.; Kaiser Permanente Bernard J. Tyson School of Medicine, Pasadena, CA, USA., Campora L; GSK Vaccines, Wavre, Belgium., Ceregido MA; GSK Vaccines, Wavre, Belgium., Kuznetsova A; GSK Vaccines, Wavre, Belgium., Poirrier JE; GSK Vaccines, Wavre, Belgium.; Parexel International, Wavre, Belgium., Rosillon D; GSK Vaccines, Wavre, Belgium.; DESiRE-Consulting, Sorée, Belgium., Valdes L; GSK Vaccines, Wavre, Belgium., Cheuvart B; GSK Vaccines, Wavre, Belgium., Mesaros N; GSK Vaccines, Wavre, Belgium.; The Janssens Pharmaceutical Companies of Johnson & Johnson, Beerse, Belgium., Meyer N; GSK Vaccines, Wavre, Belgium., Guignard A; GSK Vaccines, Wavre, Belgium., Tseng HF; Department of Research and Evaluation, Southern California Permanente Medical Group, Kaiser Permanente Southern California, Kaiser Permanente, 100 S Los Robles Ave, 2nd Floor, Pasadena, CA, 91101, USA.; Kaiser Permanente Bernard J. Tyson School of Medicine, Pasadena, CA, USA.

المصدر: Infectious diseases and therapy [Infect Dis Ther] 2023 Feb; Vol. 12 (2), pp. 411-423. Date of Electronic Publication: 2022 Dec 15.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Adis Country of Publication: New Zealand NLM ID: 101634499 Publication Model: Print-Electronic Cited Medium: Print ISSN: 2193-8229 (Print) Linking ISSN: 21936382 NLM ISO Abbreviation: Infect Dis Ther Subsets: PubMed not MEDLINE

المؤلفون: Dayan GH; Sanofi, Swiftwater, PA, USA., Rouphael N; Emory University Hop eClininc, Atlanta, GA, USA., Walsh SR; Harvard Medical School, Boston, MA, USA., Chen A; Sanofi, Swiftwater, PA, USA., Grunenberg N; Fred Hutchinson Cancer Center, Seattle, WA, USA., Allen M; National Institute of Allergy and Infectious Diseases / National Institutes of Health, Bethedsa, MA, USA., Antony J; Sanofi, Frankfurt, Germany., Asante KP; Research and Development Division, Ghana Health Service, Kintampo North Municipality, Ghana., Bhate AS; Jeevan Rekha Hospital, Belgavi, India., Beresnev T; National Institute of Allergy and Infectious Diseases / National Institutes of Health, Bethedsa, MA, USA., Bonaparte MI; Sanofi, Swiftwater, PA, USA., Ceregido MA; GSK, Wavre, Belgium., Dobrianskyi D; Medical Centre, Medical Clinic Blagomed LLC, Kyiv, Ukraine., Fu B; Sanofi, Swiftwater, PA, USA., Grillet MH; Sanofi, Lyon, France., Keshtkar-Jahromi M; National Institute of Health, Rockville, Maryland.; John Hopkins University School of Medicine, Baltimore, Maryland., Juraska M; Fred Hutchinson Cancer Center, Seattle, WA, USA., Kee JJ; Fred Hutchinson Cancer Center, Seattle, WA, USA., Kibuuka H; Makerere University Walter Reed Project, Kampala, Uganda., Koutsoukos M; GSK, Wavre, Belgium., Masotti R; Sanofi, Swiftwater, PA, USA., Michael NL; Walter Reed Army Institute of Research, MD, USA., Reynales H; Centro de Attencion e Investigation Medica S.A.S. - Caimed Chía, Chía, Colombia., Robb ML; The Henry M Jackson Foundation for the Advancement of Military Medicine, Bethesda, MA, USA., Villagómez Martínez SM; Hospital de Temixco en acuerdo con el Instituto Nacional de Pediatria, México., Sawe F; Kenya Medical Research Institute - US Army Medical Research, Kisumu, Kenya., Schuerman L; GSK, Wavre, Belgium., Tong T; National Institute of Allergy and Infectious Diseases / National Institutes of Health, Bethedsa, MA, USA., Treanor J; Tunnell Government Services in support of Biomedical Advanced Research and Development Authority (BARDA), Administration for Strategic Preparedness and Response (ASPR), Department of Health and Human Services (HHS), Washington, DC, USA., Wartel TA; International Vaccine Institute, Seoul, South Korea., Diazgranados CA; Sanofi, Swiftwater, PA, USA., Chicz RM; Sanofi, Cambridge, MA, USA., Gurunathan S; Sanofi, Swiftwater, PA, USA., Savarino S; Sanofi, Swiftwater, PA, USA., Sridhar S; Sanofi, Reading, UK.

مؤلفون مشاركون: VAT00008 study team

المصدر: MedRxiv : the preprint server for health sciences [medRxiv] 2023 Jan 13. Date of Electronic Publication: 2023 Jan 13.

نوع المنشور: Preprint

بيانات الدورية: Country of Publication: United States NLM ID: 101767986 Publication Model: Electronic Cited Medium: Internet NLM ISO Abbreviation: medRxiv Subsets: PubMed not MEDLINE

المؤلفون: Gobeil P; Medicago Inc., Suite 600, 1020 route de l'Église, Québec, QC, G1V 3V9, Canada., Pillet S; Medicago Inc., Suite 600, 1020 route de l'Église, Québec, QC, G1V 3V9, Canada., Boulay I; Medicago Inc., Suite 600, 1020 route de l'Église, Québec, QC, G1V 3V9, Canada., Charland N; Medicago Inc., Suite 600, 1020 route de l'Église, Québec, QC, G1V 3V9, Canada., Lorin A; Medicago Inc., Suite 600, 1020 route de l'Église, Québec, QC, G1V 3V9, Canada., Cheng MP; The Research Institute of the McGill University Health Centre, 1001 Decarie Street, Montreal, QC, H4A 3J1, Canada., Vinh DC; The Research Institute of the McGill University Health Centre, 1001 Decarie Street, Montreal, QC, H4A 3J1, Canada., Boutet P; GlaxoSmithKline (Vaccines), Avenue Fleming 20, 1300, Wavre, Belgium., Van Der Most R; GlaxoSmithKline (Vaccines), rue de l'Institut 89, 1330, Rixensart, Belgium.; BioNTech, An der Goldgrube 12, 55131, Mainz, Germany., Roman F; GlaxoSmithKline (Vaccines), Avenue Fleming 20, 1300, Wavre, Belgium., Ceregido MA; GlaxoSmithKline (Vaccines), Avenue Fleming 20, 1300, Wavre, Belgium., Landry N; Medicago Inc., Suite 600, 1020 route de l'Église, Québec, QC, G1V 3V9, Canada., D'Aoust MA; Medicago Inc., Suite 600, 1020 route de l'Église, Québec, QC, G1V 3V9, Canada., Ward BJ; Medicago Inc., Suite 600, 1020 route de l'Église, Québec, QC, G1V 3V9, Canada. wardb@medicago.com.; The Research Institute of the McGill University Health Centre, 1001 Decarie Street, Montreal, QC, H4A 3J1, Canada. wardb@medicago.com.

المصدر: Nature communications [Nat Commun] 2022 Nov 12; Vol. 13 (1), pp. 6905. Date of Electronic Publication: 2022 Nov 12.

نوع المنشور: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE

مواضيع طبية MeSH: COVID-19*/prevention & control , Vaccines, Virus-Like Particle* , Viral Vaccines*, Adult ; Humans ; Antibodies, Neutralizing ; Antibodies, Viral ; COVID-19 Vaccines ; Immunity ; SARS-CoV-2 ; Spike Glycoprotein, Coronavirus

SCR Organism: SARS-CoV-2 variants

المؤلفون: Charland N; Medicago Inc., 1020 route de l'Église, Bureau 600, Québec, QC, Canada., Gobeil P; Medicago Inc., 1020 route de l'Église, Bureau 600, Québec, QC, Canada., Pillet S; Medicago Inc., 1020 route de l'Église, Bureau 600, Québec, QC, Canada., Boulay I; Medicago Inc., 1020 route de l'Église, Bureau 600, Québec, QC, Canada., Séguin A; Medicago Inc., 1020 route de l'Église, Bureau 600, Québec, QC, Canada., Makarkov A; Medicago Inc., 1020 route de l'Église, Bureau 600, Québec, QC, Canada., Heizer G; Medicago Inc., 1020 route de l'Église, Bureau 600, Québec, QC, Canada., Bhutada K; Medicago Inc., 1020 route de l'Église, Bureau 600, Québec, QC, Canada., Mahmood A; Medicago Inc., 1020 route de l'Église, Bureau 600, Québec, QC, Canada., Trépanier S; Medicago Inc., 1020 route de l'Église, Bureau 600, Québec, QC, Canada., Hager K; Medicago Inc., 1020 route de l'Église, Bureau 600, Québec, QC, Canada.; Vertex Pharmaceticals, 50 Northern Avenue, Boston, MA, USA., Jiang-Wright J; Medicago Inc., 1020 route de l'Église, Bureau 600, Québec, QC, Canada., Atkins J; Medicago Inc., 1020 route de l'Église, Bureau 600, Québec, QC, Canada., Saxena P; Medicago Inc., 1020 route de l'Église, Bureau 600, Québec, QC, Canada., Cheng MP; Research Institute of the McGill University Health Centre, 1001 Decarie St, Montréal, QC, Canada., Vinh DC; Research Institute of the McGill University Health Centre, 1001 Decarie St, Montréal, QC, Canada., Boutet P; GSK, Wavre, Belgium., Roman F; GSK, Wavre, Belgium., Van Der Most R; GSK, Wavre, Belgium.; BioNTech SE, An der Goldgrube 12, Mainz, Germany., Ceregido MA; GSK, Wavre, Belgium., Dionne M; CHU de Québec-Université Laval, 2400 d'Estimauville, Québec City, QC, Canada., Tellier G; Manna Research, 101-13714 Boul Du Curé-Labelle, Suite 101, Mirabel, QC, Canada., Gauthier JS; Q&T Research Sherbrooke Inc., 2185 King Street West, Suite 101, Sherbrooke, QC, Canada., Essink B; Meridian Clinical Research, 3319 N 107th St, Omaha, NE, USA., Libman M; Research Institute of the McGill University Health Centre, 1001 Decarie St, Montréal, QC, Canada., Haffizulla J; Precision Clinical Research, 8399 West Oakland Park Blvd., Suite B & C, Sunrise, FL, USA., Fréchette A; Diex Research Québec Inc., 205 rue Montmagny, Suite 103, Québec City, QC, Canada., D'Aoust MA; Medicago Inc., 1020 route de l'Église, Bureau 600, Québec, QC, Canada., Landry N; Medicago Inc., 1020 route de l'Église, Bureau 600, Québec, QC, Canada., Ward BJ; Medicago Inc., 1020 route de l'Église, Bureau 600, Québec, QC, Canada. wardb@medicago.com.; Research Institute of the McGill University Health Centre, 1001 Decarie St, Montréal, QC, Canada. wardb@medicago.com.

المصدر: NPJ vaccines [NPJ Vaccines] 2022 Nov 09; Vol. 7 (1), pp. 142. Date of Electronic Publication: 2022 Nov 09.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Springer Nature in partnership with the Sealy Center for Vaccine Development Country of Publication: England NLM ID: 101699863 Publication Model: Electronic Cited Medium: Internet ISSN: 2059-0105 (Electronic) Linking ISSN: 20590105 NLM ISO Abbreviation: NPJ Vaccines Subsets: PubMed not MEDLINE